183 related articles for article (PubMed ID: 18325219)
21. Immunocytology in the assessment of patients with painless gross haematuria.
Schmitz-Dräger B; Tirsar LA; Schmitz-Dräger C; Dörsam J; Bismarck E; Ebert T
BJU Int; 2008 Feb; 101(4):455-8. PubMed ID: 18005211
[TBL] [Abstract][Full Text] [Related]
22. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.
Kumar A; Kumar R; Gupta NP
Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358
[TBL] [Abstract][Full Text] [Related]
23. Utility of urine cytology in the workup of asymptomatic microscopic hematuria in low-risk patients.
Feifer AH; Steinberg J; Tanguay S; Aprikian AG; Brimo F; Kassouf W
Urology; 2010 Jun; 75(6):1278-82. PubMed ID: 20138655
[TBL] [Abstract][Full Text] [Related]
24. Voided urine versus bladder washing cytology for detection of urothelial carcinoma: which is better?
Keller AK; Jensen JB
Scand J Urol; 2017 Aug; 51(4):290-292. PubMed ID: 28398114
[TBL] [Abstract][Full Text] [Related]
25. A multigene urine test for the detection and stratification of bladder cancer in patients presenting with hematuria.
O'Sullivan P; Sharples K; Dalphin M; Davidson P; Gilling P; Cambridge L; Harvey J; Toro T; Giles N; Luxmanan C; Alves CF; Yoon HS; Hinder V; Masters J; Kennedy-Smith A; Beaven T; Guilford PJ
J Urol; 2012 Sep; 188(3):741-7. PubMed ID: 22818138
[TBL] [Abstract][Full Text] [Related]
26. Human complement factor H related protein test for monitoring bladder cancer.
Raitanen MP; Marttila T; Nurmi M; Ala-Opas M; Nieminen P; Aine R; Tammela TL;
J Urol; 2001 Feb; 165(2):374-7. PubMed ID: 11176376
[TBL] [Abstract][Full Text] [Related]
27. Fluorescence in situ hybridization assay detects upper urinary tract transitional cell carcinoma in patients with asymptomatic hematuria and negative urine cytology.
Huang WT; Li LY; Pang J; Ruan XX; Sun QP; Yang WJ; Gao X
Neoplasma; 2012; 59(4):355-60. PubMed ID: 22489689
[TBL] [Abstract][Full Text] [Related]
28. Results of Bard BTA test in monitoring patients with a history of transitional cell cancer of the bladder.
Ianari A; Sternberg CN; Rossetti A; Van Rijn A; Deidda A; Giannarelli D; Pansadoro V
Urology; 1997 May; 49(5):786-9. PubMed ID: 9145993
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis of bladder tumours in patients with macroscopic haematuria: a prospective comparison of split-bolus computed tomography urography, magnetic resonance urography and flexible cystoscopy.
Gandrup KL; Løgager VB; Bretlau T; Nordling J; Thomsen HS
Scand J Urol; 2015 Jun; 49(3):224-9. PubMed ID: 25438986
[TBL] [Abstract][Full Text] [Related]
30. Does subdivision of the "atypical" urine cytology increase predictive accuracy for urothelial carcinoma?
Bostwick DG; Hossain D
Diagn Cytopathol; 2014 Dec; 42(12):1034-44. PubMed ID: 24838797
[TBL] [Abstract][Full Text] [Related]
31. Cytology in the diagnosis and followup of transitional cell carcinoma of the urothelium: a review with a case series.
Lewis RW; Jackson AC; Murphy WM; Leblanc GA; Meehan WL
J Urol; 1976 Jul; 116(1):43-6. PubMed ID: 933287
[TBL] [Abstract][Full Text] [Related]
32. Optimizing Upper-Tract Imaging for Non-Visible Haematuria.
Michael KGFT; Ravindranath N; Michael S; German A; Riley T; Calleary JG; Bourdoumis A; Surange R
Urol Int; 2023; 107(1):23-28. PubMed ID: 36041410
[TBL] [Abstract][Full Text] [Related]
33. The Effects of Instrumentation on Urine Cytology and CK-20 Analysis for the Detection of Bladder Cancer.
Wegelin O; Bartels DW; Tromp E; Kuypers KC; van Melick HH
Urology; 2015 Oct; 86(4):772-6. PubMed ID: 26166668
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic efficacy of the combination of urine cytology, urine analysis and history in the follow-up of bladder carcinoma.
Meuleman EJ; Delaere KP
Br J Urol; 1988 Aug; 62(2):150-3. PubMed ID: 3408887
[TBL] [Abstract][Full Text] [Related]
35. Routine follow-up cystoscopy in detection of recurrence in patients being monitored for bladder cancer.
Raitanen MP; Leppilahti M; Tuhkanen K; Forssel T; Nylund P; Tammela T;
Ann Chir Gynaecol; 2001; 90(4):261-5. PubMed ID: 11820414
[TBL] [Abstract][Full Text] [Related]
36. Urinary beta-glucuronidase activity as an initial screening test for urinary tract malignancy in high risk patients. Comparison with conventional urine cytologic evaluation.
Ho KJ; Kuo SH
Cancer; 1995 Aug; 76(3):473-8. PubMed ID: 8625129
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic value of a urine-based tumor marker for screening lower urinary tract in low-risk patients with asymptomatic microscopic hematuria.
Sagnak L; Ersoy H; Gucuk O; Ozok U; Topaloglu H
Urol Int; 2011; 87(1):35-41. PubMed ID: 21654152
[TBL] [Abstract][Full Text] [Related]
38. Patients with a negative cystoscopy and negative Nmp22® Bladderchek® test are at low risk of missed transitional cell carcinoma of the bladder: a prospective evaluation.
Terrell JD; Elias KJ; Sagalowsky AI; Lotan Y
Int Braz J Urol; 2011; 37(6):706-11. PubMed ID: 22234001
[TBL] [Abstract][Full Text] [Related]
39. [Urinary cytology in cases of bladder cancer: a critical evaluation].
Rathert P
Urologe A; 2003 Jul; 42(7):908-11. PubMed ID: 12898033
[TBL] [Abstract][Full Text] [Related]
40. [Methods and current significance of the evaluation of microscopic haematuria].
Hüppe P; Wawroschek F
Urologe A; 2011 Mar; 50(3):287-91. PubMed ID: 21365348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
